- Alexander, Margaret;
- Upadhyay, Vaibhav;
- Rock, Rachel;
- Ramirez, Lorenzo;
- Trepka, Kai;
- Puchalska, Patrycja;
- Orellana, Diego;
- Ang, Qi;
- Whitty, Caroline;
- Turnbaugh, Jessie;
- Tian, Yuan;
- Dumlao, Darren;
- Nayak, Renuka;
- Patterson, Andrew;
- Newman, John;
- Crawford, Peter;
- Turnbaugh, Peter
Diet can protect from autoimmune disease; however, whether diet acts via the host and/or microbiome remains unclear. Here, we use a ketogenic diet (KD) as a model to dissect these complex interactions. A KD rescued the experimental autoimmune encephalomyelitis (EAE) mouse model of multiple sclerosis in a microbiota-dependent fashion. Dietary supplementation with a single KD-dependent host metabolite (β-hydroxybutyrate [βHB]) rescued EAE, whereas transgenic mice unable to produce βHB in the intestine developed more severe disease. Transplantation of the βHB-shaped gut microbiota was protective. Lactobacillus sequence variants were associated with decreased T helper 17 cell activation in vitro. Finally, we isolated an L. murinus strain that protected from EAE, which was phenocopied by a Lactobacillus metabolite enriched by βHB supplementation, indole lactate. Thus, diet alters the immunomodulatory potential of the gut microbiota by shifting host metabolism, emphasizing the utility of taking a more integrative approach to study diet-host-microbiome interactions.